We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Serum High Sensitivity C-Reactive Protein Associated With Pre-Diabetes

By LabMedica International staff writers
Posted on 29 Dec 2021
Individuals with pre-diabetes are at a higher risk for progression to diabetes and are also known to be associated with an increased risk of cardiovascular disease. More...
Also, pre-diabetes is known to be associated with obesity and an abnormal lipid profile.

C-reactive protein (CRP) is an acute-phase protein that is increased in infections, inflammatory conditions, and even cancers. Low-grade inflammation is said to be associated with pre-diabetes and high sensitivity CRP (hsCRP) is an indicator of inflammation.

Clinical Scientists at the Jawaharlal Nehru Medical College (Wardha, India) carried out a cross-sectional study from October 2018 to August 2020 to determine whether hsCRP can be used as a biomarker in the early diagnosis of pre-diabetes in a rural population. A total of 200 participants, including 100 diabetics and 100 controls who were age- and gender-matched, were enrolled. Blood investigations included blood glucose levels, lipid profile, and high sensitivity CRP. The hsCRP levels were tested by an ultrasensitive CRP kit, and were measured by the spectrophotometric method using an enzyme-linked immunosorbent assay (ELISA) Turbichem-Hs-CRP kit, (Genuine Biosystem, Chennai, India). The test was based on the two-site sandwich enzyme immunoassay principle.

The investigators reported that the mean value of high sensitivity CRP for cases was 2.17 ± 0.72 mg/L. The mean value of high sensitivity CRP for controls was 0.66 ± 0.22 mg/L and therefore high sensitivity CRP for diabetics was significantly higher than controls. High sensitivity CRP was significantly and positively correlated to age, body mass index (BMI), total cholesterol, low-density lipoprotein, cholesterol, and waist-hip ratio.

The authors concluded that Hs-CRP, which is a marker of inflammation, was also found to be correlated with abnormal lipid profiles and oral glucose tolerance tests. The Hs-CRP can be used as an early predictor of inflammation in pre-diabetes and can be a marker of underlying abnormal sugar levels and lipid profile in pre-diabetics unaware of their health status. The study was published on October 28, 2021 in the journal Cureus.

Related Links:
Jawaharlal Nehru Medical College
Genuine Biosystem



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.